Intercept Pharmaceuticals Announces Two New Sub-Groups For FLINT Trial: Analysts Comment By: TalkMarkets March 24, 2015 at 21:01 PM EDT Intercept Pharmaceuticals develops drug treatments for chronic liver diseases. Read More >> Related Stocks: Intercept Pharmaceuticals